Lebrikizumab Performs Well in AD Patients With Darker Skin Types
The Dermatology Digest
MARCH 10, 2024
The initial 16-week data from this study evaluated 50 patients with moderate-to-severe atopic dermatitis and darker skin tones as measured by the Fitzpatrick scale, including people who self-identify as Black or African American (80%), Asian (14%), American Indian or Alaska Native (6%). and the rest of the world outside Europe.
Let's personalize your content